Quick Answer
AMPHENOL CORP /DE/ reported Cash and Equivalents of $11.13 billion for fiscal year 2025.
AMPHENOL CORP /DE/ Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $11.13B | +235.6% |
| 2024 | $3.32B | +124.9% |
| 2023 | $1.48B | +7.4% |
| 2022 | $1.37B | +14.7% |
| 2021 | $1.20B | -29.7% |
| 2020 | $1.70B | +91.0% |
| 2019 | $891.20M | -30.3% |
| 2018 | $1.28B | -25.6% |
| 2017 | $1.72B | +66.2% |
| 2016 | $1.03B | -40.4% |
| 2015 | $1.74B | +79.3% |
| 2014 | $968.90M | +9.3% |
| 2013 | $886.80M | +28.4% |
| 2012 | $690.80M | +34.1% |
| 2011 | $515.10M | -2.1% |
| 2010 | $525.89M | +36.7% |
| 2009 | $384.61M | +78.9% |
| 2008 | $214.99M | +17.1% |
| 2007 | $183.64M | +147.7% |
| 2006 | $74.14M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.80B | +143.1% | +18.5% |
| June 30, 2025 | $3.21B | +156.0% | +93.5% |
| March 31, 2025 | $1.66B | -10.8% | -50.0% |
| December 31, 2024 | $3.32B | +124.9% | +112.2% |
| September 30, 2024 | $1.56B | +5.5% | +24.8% |
| June 30, 2024 | $1.25B | -5.5% | -32.6% |
| March 31, 2024 | $1.86B | +33.5% | +25.9% |
| December 31, 2023 | $1.48B | +7.4% | -0.4% |
- AMPHENOL CORP /DE/ showed an increase of +235.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2006–2025 period, AMPHENOL CORP /DE/’s cash and equivalents has grown by 14914.0% (from $74.14 million to $11.13 billion).
- The most recent figure is from AMPHENOL CORP /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: